Terapia CAR-T costo en China

Los precios reportados de Terapia CAR-T en China van de unos $65,000 a $181,690 (USD) 8 registros con fuente (2024, 2025, 2026). Las fuentes difieren; nunca promediamos.

Todas las entradas

AmountCity / hospitalIncludesPatient typeYearSourceStatus
$150,000 to $180,000 -细胞采集与制备, 住院, 报道中的治疗全程international-dept2026AFP / Free Malaysia TodayReportado
Verificado
$65,000 -recolección y fabricación de células, episodio de tratamiento según lo reportadointernational-dept2026AFP / Free Malaysia TodayReportado
Verificado
¥999,000 to ¥1,290,000 about $140,704 to $181,690-手术及8天住院,患者自述unknown2024International Journal of Health Policy and Management (via PMC)Reportado
Verificado
¥1,200,000 about $169,014-Precio de lista nacional de axicabtagene ciloleucel (Yikaida), primer producto CAR-T aprobado en China, por infusión, Solo precio del fármaco; hospitalización y monitoreo no especificados, Según informe de 2024, el plan del fabricante basado en resultados reembolsa hasta 600.000 CNY si no se alcanza la remisión completaunknown2024Securities Times (citing National Business Daily)Reportado
Verificado
$150,000 to $180,000 -single CAR-T infusion (equivalent to US product)unknown2026The Straits Times / BloombergReportado
Verificado
$65,000 shanghaiclinical trial treatment, hospital care, airfareinternational-dept2025The Straits Times / BloombergReportado
Verificado
¥990,000 about $139,437shanghaisingle CAR-T injection for solid tumorunknown2026The Insight Asia / CaijingReportado
Verificado
$65,000 -alojamiento hospitalario para el paciente, comidas para dos personas, transporte desde y hacia el aeropuertounknown2025Facebook group: MULTIPLE MYELOMA SUPPORT GROUPAutoinformado
Verificado

Que observar

Fuentes

  1. China lures foreign patients with cutting-edge, cheap medical care
    AFP / Free Malaysia Today · news · accessed 2026-10-26
    “2026-10-26”
  2. China lures foreign patients with cutting-edge, cheap medical care
    AFP / Free Malaysia Today · news · accessed 2026-10-26
    “New Zealand patient Stuart Lye's total cost was reported around USD 65,000.”
  3. A New Outcomes-Based Payment Plan From a Chinese Company to Improve Patient Affordability of CAR-T Product
    International Journal of Health Policy and Management (via PMC) · news · accessed 2026-10-26
    “The current list pricing ranges between 0.999 million and 1.29 million RMB per infusion, far more expensive than standard-of-care therapies.”
  4. Gilead's Kite exits China cell therapy JV with Fosun Pharma
    Fierce Pharma · news · accessed 2026-10-26
    “The list price for Yescarta in China is 1.2 million yuan (about $170,000).”
  5. 价格高达百万元的CAR-T产品如何打通“最后一公里”?
    Securities Times (citing National Business Daily) · news · accessed 2026-10-26
    “奕凯达是中国首款获批的CAR-T细胞治疗产品,国内定价为120万元一针。”
  6. China Focus: More health insurance coverage for cancer patients in China
    Xinhua · news · accessed 2026-10-26
    “it was once priced at over 1 million yuan per infusion.”
  7. China lures foreign patients with cutting-edge, cheap medical care (Bloomberg)
    The Straits Times / Bloomberg · news · accessed 2026-10-26
  8. China lures foreign patients with cutting-edge, cheap medical care (Bloomberg)
    The Straits Times / Bloomberg · news · accessed 2026-10-26
  9. A $137,000 cancer shot brings foreign patients to China (from Caijing)
    The Insight Asia / Caijing · news · accessed 2026-10-26
  10. BCMA CAR-T treatment option in Kunming, China (public post)
    Facebook group: MULTIPLE MYELOMA SUPPORT GROUP · self-reported · accessed 2026-10-26

Solo informacion. No es consejo medico, diagnostico ni recomendacion de tratamiento. Consulte a su medico. En una emergencia, llame a su numero local de emergencias.